摘要
目的:探讨胺碘酮对急性心肌梗死伴高危快速型心律失常的有效性和安全性。方法:2004年2月2007年8月我院急诊抢救室、冠心病重症监护室收治急性心肌梗死伴高危快速型心律失常235例,分室上性(AV)组和室性(V)组,AV组分为治疗(AVA)组和对照(AVC)组,AVA组予以胺碘酮,AVC组予以普罗帕酮治疗。V组亦分为治疗(VA)组和对照(VC)组,AVA组予以胺碘酮,AVC组予以利多卡因治疗。通过临床治疗比较治疗组和对照组的有效性和安全性。结果:治疗组(AVA+VA)总有效率89.1%,而对照组(AVC+VC)65.5%,两组相比差异显著。结论:急性心肌梗死伴高危快速型心律失常时静脉注射胺碘酮能有效予以控制。
Objective：To explore the effect and security of Amiodarone on tachyarrhymia in acute myo- cardial infarction. Methods： Two hundreds and thirty - five patients were divided into two groups ： supravent- ricular tachyarrhythmia group （ AV ） and ventricular tachyarrhythmia （ V ）. AV was treated with Amiodarone as group AVA, and treated with Propafenone as group AVC. V was treated with Amiodarone as groups VA, while treated with Lidocaine as group VC. Effect and security were recorded. Results：The effective rate treated by Amiodarone （ AVA ＋ VA ） was 89.1%. The effective rate of control groups was 65.5%. It had significant difference between two groups. Conelusion：Amiodarone used to treated tachyarrhymia in acute myocardial infarction can be more effective and securely.
出处
《河北医学》
CAS
2008年第3期303-306,共4页
Hebei Medicine
关键词
胺碘酮
急性心肌梗死
心律失常
Amiodarone
Acute myocardial infarction
Arrhythmia
